Kadimastem (XTAE:KDST) Total Liabilities : ₪12.73 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Kadimastem Total Liabilities?

Kadimastem's Total Liabilities for the quarter that ended in Dec. 2023 was ₪12.73 Mil.

Kadimastem's quarterly Total Liabilities declined from Dec. 2022 (₪12.16 Mil) to Jun. 2023 (₪9.40 Mil) but then increased from Jun. 2023 (₪9.40 Mil) to Dec. 2023 (₪12.73 Mil).

Kadimastem's annual Total Liabilities increased from Dec. 2021 (₪11.96 Mil) to Dec. 2022 (₪12.16 Mil) and increased from Dec. 2022 (₪12.16 Mil) to Dec. 2023 (₪12.73 Mil).

Kadimastem Total Liabilities Historical Data

The historical data trend for Kadimastem's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kadimastem Total Liabilities Chart

Kadimastem Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

19.32

18.85

11.96

12.16

12.73

Kadimastem Semi-Annual Data
	Dec13	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial														11.96	13.76	12.16	9.40	12.73

Kadimastem Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Kadimastem's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8.239	+	(0.834	+	3.634
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.019)
	=	12.73

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	8.366	-	-4.36
	=	12.73

Kadimastem's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8.239	+	(0.834	+	3.634
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.019)
	=	12.73

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	8.366	-	-4.36
	=	12.73

Kadimastem Total Liabilities Related Terms

Thank you for viewing the detailed overview of Kadimastem's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Kadimastem (XTAE:KDST) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kadimastem Ltd (XTAE:KDST) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

KMSTF:USA

Address

Pinchas Sapir 7, Weizmann Science Park, Nes-Ziona, ISR

Website

http://www.kadimastem.com

Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.

Kadimastem (XTAE:KDST) Headlines

No Headlines